Generics will take as much of the market as they can get ...until something stops them . Whats limiting them so far ...IMHO ...is the exclusivity contracts that AMRN has with health providers like Kaiser. So AMRN IMHO is matching the generics price to Kaiser ...in exchange for volume . Kaiser gets the same price and doesn't have to think about HealthNet type lawsuits ...Lawsuits can get expensive Kiwi